Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Hemangiosarcoma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1

Interventions

Cisplatin 14Radiotherapy 13Oxaliplatin 8Fluorouracil 7Gemcitabine 6Drug Therapy 6Leucovorin 5Doxorubicin 5Cytarabine 5Cyclophosphamide 5Carboplatin 5Capecitabine 5durvalumab 4Paclitaxel 4Etoposide 4Docetaxel 4Chemotherapy, Adjuvant 4Biological Therapy 4bicalutamide 3Rituximab 3Radiotherapy, Intensity-Modulated 3Polymerase Chain Reaction 3Platinum 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Gene Expression Profiling 3Dexamethasone 3Bortezomib 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × NETWORK × Glutamine × Clear all
NCT00334984 2013-07-11

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Children's Oncology Group

Phase NA Withdrawn
Sarcoma

Malignant mesenchymal tumor, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Dermatofibrosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡